Crosstalk between metabolic and neuropsychiatric disorders

F1000 Biology Reports

Volumn 4, Issue 1, 2012, Pages

  Kaidanovich Beilin, Oksana ^a   Cha, Danielle S ^b   McIntyre, Roger S ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLUCOSE; INSULIN; LEPTIN; RESISTIN;

ALZHEIMER DISEASE; BODY MASS; BRAIN METABOLISM; CYTOKINE RELEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GLUCOSE METABOLISM; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUNGER; HUNTINGTON CHOREA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; MENTAL DISEASE; METABOLIC DISORDER; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; STARVATION; STRESS;

ANIMALIA;

EID: 84863578451     PISSN: 17404118     EISSN: 1757594X     Source Type: Journal    
DOI: 10.3410/B4-14     Document Type: Review

References (129)

1. Willis T, "Pharmaceuticerationalissivediatriba de medicamentorumoperationibus in humanocorpore." E TheatroSheldoniano M.DC.LXXV: Oxford, 1675 [ISBN: 978-1240416721].
2. Mukherjee S, Schnur DB, Reddy R: Family history of type 2 diabetes in schizophrenic patients. Lancet 1989, 1:495. (Pubitemid 19063553)
3. Menninger W: Psychological factors in etiology of diabetes. J NervMent Dis 1935, 81:1-13.
4. Sakel M: The methodical use of hypoglycemia in the treatment of psychoses. 1937. Am J Psychiatry 1994, 151:240-7.
5. Dwyer DS, Lu X, Iii AMF: Neuronal glucose metabolism and schizophrenia: therapeutic prospects? Expert Rev Neurother 2003, 3:29-40. (Pubitemid 36077407)
6. Mezuk B, Eaton WW, Albrecht S, Golden SH: Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31:2383-90. F1000 Factor 6 Evaluated by Roger McIntyre 13 Jun 2012
7. Pouwer F, Beekman ATF, Nijpels G, Dekker JM, Snoek FJ, Kostense PJ, Heine RJ, Deeg DJH: Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia 2003, 46:892-8. (Pubitemid 36961312)
8. Musselman DL, Betan E, Larsen H, Phillips LS: Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003, 54:317-29. (Pubitemid 37267861)
9. Lustman PJ, Clouse RE: Depression in diabetic patients: the relationship between mood and glycemic control. J Diabetes Complicat 2005, 19:113-22. (Pubitemid 40312625)
10. Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, Lehman A: Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 2000, 26:903-12. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
11. Schwartz TL, Nihalani N, Jindal S, Virk S, Jones N: Psychiatric medication-induced obesity: a review. Obes Rev 2004, 5:115-21. (Pubitemid 38623165)
12. McIntyre RS, Mancini DA, Basile VS: Mechanisms of antipsychotic-induced weight gain. J Clin Psychiatry 2001, 62(Suppl 23):23-9. (Pubitemid 32952691)
13. Girgis RR, Javitch JA, Lieberman JA: Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway. Mol Psychiatry 2008, 13:918-29. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
14. Bruce DG, Harrington N, Davis WA, Davis TM: Dementia and its associations in type 2 diabetes mellitus: the Fremantle Diabetes Study. Diabetes Res Clin Pract 2001, 53:165-72. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
15. Yoshitake T, Kiyohara Y, Kato I, Ohmura T, Iwamoto H, Nakayama K, Ohmori S, Nomiyama K, Kawano H, Ueda K: Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995, 45:1161-8.
16. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 2002, 51:1256-62. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
17. Sandyk R: The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 1993, 69:125-30. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
18. van Woert MH, Mueller PS: Glucose, insulin, and free fatty acid metabolism in Parkinson's disease treated with levodopa. Clin Pharmacol Ther 1971, 12:360-7. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
19. Sirtori CR, Bolme P, Azarnoff DL: Metabolic responses to acute and chronic L-dopa administration in patients with parkinsonism. N Engl J Med 1972, 287:729-33. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
20. Podolsky S, Leopold NA, Sax DS: Increased frequency of diabetes mellitus in patients with Huntington's chorea. Lancet 1972, 1:1356-8. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
21. Podolsky S, Leopold NA: Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease. Gerontology 1977, 23:55-63.
22. Farrer LA: Diabetes mellitus in Huntington disease. Clin Genet 1985, 27:62-7.
23. Ristow M: Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 2004, 82:510-29.
24. Viljoen A, Sinclair AJ: Diabetes and insulin resistance in older people. Med Clin North Am 2011, 95:615-29 xi-ii. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
25. Barzilai N, Gabriely I, Atzmon G, Suh Y, Rothenberg D, Bergman A: Genetic studies reveal the role of the endocrine and metabolic systems in aging. J Clin Endocrinol Metab 2010, 95:4493-500.
26. KEYS A: The residues of malnutrition and starvation. Science 1950, 112:371-3. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
27. Attia E: Anorexia nervosa: current status and future directions. Annu Rev Med 2010, 61:425-35.
28. Hoek HW: Incidence, prevalence and mortality of anorexia nervosa and other eating disorders. CurrOpin Psychiatry 2006, 19:389-94.
29. Zandian M, Ioakimidis I, Bergh C, Södersten P: Cause and treatment of anorexia nervosa. Physiol Behav 2007, 92:283-90. (Pubitemid 47381383)
30. Bergh C, Södersten P: Anorexia nervosa, self-starvation and the reward of stress. Nat Med 1996, 2:21-2. (Pubitemid 26029568)
31. Dwyer DS, Horton RY, Aamodt EJ: Role of the evolutionarily conserved starvation response in anorexia nervosa. Mol Psychiatry 2011, 16:595-603.
32. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S: Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci U.S.A 2003, 100:11696-701. F1000 Factor 8 Evaluated by Robert Sapolsky 03 Oct 2003
33. Teegarden SL, Bale TL: Decreases in dietary preference produce increased emotionality and risk for dietary relapse. Biol Psychiatry 2007, 61:1021-9. (Pubitemid 46551977)
34. Swann AC, Stokes PE, Casper R, Secunda SK, Bowden CL, Berman N, Katz MM, Robins E: Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. ActaPsychiatrScand 1992, 85:270-4.
35. Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH: Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004, 184:496-502. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
36. McMahon M, Gerich J, Rizza R: Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 1988, 4:17-30. (Pubitemid 18072099)
37. Desbriere R, Vuaroqueaux V, Achard V, Boullu-Ciocca S, Labuhn M, Dutour A, Grino M: 11beta-hydroxysteroid dehydrogenase type 1 mRNA is increased in both visceral and subcutaneous adipose tissue of obese patients. Obesity (Silver Spring) 2006, 14:794-8. (Pubitemid 46219720)
38. Raven PW, Taylor NF: 11Beta-HSD and 17beta-HSD as biological markers of depression: sex differences and correlation with symptom severity. Endocr Res 1998, 24:659-62. (Pubitemid 29016458)
39. Macht M: Effects of high- and low-energy meals on hunger, physiological processes and reactions to emotional stress. Appetite 1996, 26:71-88.
40. Hagan MM, Wauford PK, Chandler PC, Jarrett LA, Rybak RJ, Blackburn K: A new animal model of binge eating: key synergistic role of past caloric restriction and stress. Physiol Behav 2002, 77:45-54. (Pubitemid 35245719)
41. Coste SC, Murray SE, Stenzel-Poore MP: Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides 2001, 22:733-41. (Pubitemid 32397724)
42. Cone RD: The corticotropin-releasing hormone system and feeding behavior-a complex web begins to unravel. Endocrinology 2000, 141:2713-4.
43. Amor S, Puentes F, Baker D, van der Valk P: Inflammation in neurodegenerative diseases. Immunology 2010, 129:154-69.
44. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH: Mechanisms underlying inflammation in neurodegeneration. Cell 2010, 140:918-34.
45. Philips T, Robberecht W: Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 2011, 10:253-63.
46. McGeer PL, McGeer EG: Glial reactions in Parkinson's disease. Mov. Disord 2008, 23:474-83.
47. Miller AH, Maletic V, Raison CL: Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-41.
48. Reichenberg A, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, Pollmächer T: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445-52. (Pubitemid 32411324)
49. Anisman H, Merali Z: Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003, 35:2-11. (Pubitemid 36356868)
50. O'Brien SM, Scully P, Scott LV, Dinan TG: Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. J Affect Disord 2006, 90:263-7. (Pubitemid 43183536)
51. Schiepers OJG, Wichers MC, Maes M: Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:201-17. (Pubitemid 40202906)
52. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006, 27:24-31. (Pubitemid 43083561)
53. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56. (Pubitemid 350295688)
54. O'Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG: Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res 2007, 41:326-31. (Pubitemid 44854992)
55. Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C, Jaffuel D, Mathieu M: Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 2007, 8:35.
56. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, Lalla D, Woolley M, Jahreis A, Zitnik R, Cella D, Krishnan R: Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 2006, 367:29-35. (Pubitemid 43038667)
57. Dantzer R: Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 2004, 500:399-411. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
58. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006, 444:860-7. F1000 Factor 11 Evaluated by Marc Jeschke 25 Apr 2008, Ajay Chawla 15 Jun 2012
59. Karalis KP, Giannogonas P, Kodela E, Koutmani Y, Zoumakis M, Teli T: Mechanisms of obesity and related pathology: linking immune responses to metabolic stress. FEBS J 2009, 276:5747-54.
60. Thaler JP, Choi SJ, Schwartz MW, Wisse BE: Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol 2010, 31:79-84.
61. Pasco JA, Jacka FN, Williams LJ, Henry MJ, Nicholson GC, Kotowicz MA, Berk M: Leptin in depressed women: cross-sectional and longitudinal data from an epidemiologic study. J Affect Disord 2008, 107:221-5. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
62. Weber-Hamann B, Kratzsch J, Kopf D, Lederbogen F, Gilles M, Heuser I, Deuschle M: Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J Psychiatr Res 2007, 41:344-50. (Pubitemid 44854985)
63. Könner AC, Brüning JC: Toll-like receptors: linking inflammation to metabolism. Trends Endocrinol Metab 2011, 22:16-23.
64. Mandel MA, Mahmoud AA: Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol 1978, 120:1375-7. (Pubitemid 8334546)
65. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-70.
66. de Souza CT, Araujo EP, Bordin S, Ashimine R, Zollner RL, Boschero AC, Saad MJA, Velloso LA: Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology 2005, 146:4192-9.
67. Posey KA, Clegg DJ, Printz RL, Byun J, Morton GJ, Vivekanandan-Giri A, Pennathur S, Baskin DG, Heinecke JW, Woods SC, Schwartz MW, Niswender KD: Hypothalamic proinflammatory lipid accumulation, inflammation, and insulin resistance in rats fed a high-fat diet. Am J Physiol Endocrinol Metab 2009, 296:E1003-12. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
68. Milanski M, Degasperi G, Coope A, Morari J, Denis R, Cintra DE, Tsukumo DML, Anhe G, Amaral ME, Takahashi HK, Curi R, Oliveira HC, Carvalheira JBC, Bordin S, Saad MJ, Velloso LA: Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity. J Neurosci 2009, 29:359-70. F1000 Factor 6 Evaluated by Helen Raybould 18 Mar 2009
69. Abbott MA, Wells DG, Fallon JR: The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 1999, 19:7300-8. (Pubitemid 29404586)
70. Magistretti PJ, "Brain energymetabolism." In: "Fundamental Neuroscience."Squire LR, Berg D, Bloom FE, du Lac S, Ghosh A, Spitzer NC (eds) San Diego: Academic Press, 2008:271-293 [ISBN:978-0-12-374019-9].
71. Havrankova J, Roth J, Brownstein M: Insulin receptors are widely distributed in the central nervous system of the rat. Nature 1978, 272:827-9. (Pubitemid 8316991)
72. Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU: Insulin-responsive glucose transporters-GLUT8 and GLUT4 are expressed in the developing mammalian brain. Brain Res Mol Brain Res 2002, 107:157-65. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
73. Hörsch D, Kahn CR: Region-specific mRNA expression of phosphatidylinositol 3-kinase regulatory isoforms in the central nervous system of C57BL/6J mice. J Comp Neurol 1999, 415:105-20. (Pubitemid 29519889)
74. Baskin DG, Porte D, Guest K, Dorsa DM: Regional concentrations of insulin in the rat brain. Endocrinology 1983, 112:898-903.
75. Unger JW, Moss AM, Livingston JN: Immunohistochemical localization of insulin receptors and phosphotyrosine in the brainstem of the adult rat. Neuroscience 1991, 42:853-61.
76. Margolis RU, Altszuler N: Insulin in the cerebrospinal fluid. Nature 1967, 215:1375-6.
77. Woods SC, Seeley RJ, Baskin DG, Schwartz MW: Insulin and the blood-brain barrier. Curr Pharm Des 2003, 9:795-800. (Pubitemid 36367601)
78. Banks WA: The source of cerebral insulin. Eur J Pharmacol 2004, 490:5-12.
79. Craft S, Watson GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004, 3:169-78. (Pubitemid 38229951)
80. Woods SC, Porte D, Bobbioni E, Ionescu E, Sauter JF, Rohner-Jeanrenaud F, Jeanrenaud B: Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr 1985, 42:1063-71. (Pubitemid 16148060)
81. Woods SC, Lotter EC, McKay LD, Porte D: Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979, 282:503-5. (Pubitemid 10126541)
82. Plum L, Schubert M, Brüning JC: The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 2005, 16:59-65. (Pubitemid 40270851)
83. Air EL, Benoit SC, Blake Smith KA, Clegg DJ, Woods SC: Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 2002, 72:423-9. (Pubitemid 34251354)
84. McGowan MK, Andrews KM, Fenner D, Grossman SP: Chronic intrahypothalamic insulin infusion in the rat: behavioral specificity. Physiol Behav 1993, 54:1031-4. (Pubitemid 23303885)
85. Figlewicz DP, Bennett JL, Aliakbari S, Zavosh A, Sipols AJ: Insulin acts at different CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol Regul Integr Comp Physiol 2008, 295:R388-94. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
86. Bruijnzeel AW, Corrie LW, Rogers JA, Yamada H: Effects of insulin and leptin in the ventral tegmental area and arcuate hypothalamic nucleus on food intake and brain reward function in female rats. Behav Brain Res 2011, 219:254-64.
87. McGowan MK, Andrews KM, Kelly J, Grossman SP: Effects of chronic intrahypothalamic infusion of insulin on food intake and diurnal meal patterning in the rat. Behav Neurosci 1990, 104:373-85. (Pubitemid 20168875)
88. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L: Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002, 5:566-72. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
89. Strubbe JH, Mein CG: Increased feeding in response to bilateral injection of insulin antibodies in the VMH. Physiol Behav 1977, 19:309-13. (Pubitemid 8248736)
90. Brüning JC, Gautam D, Burks DJ, Gillette J, Schubert M, Orban PC, Klein R, Krone W, Müller-Wieland D, Kahn CR: Role of brain insulin receptor in control of body weight and reproduction. Science 2000, 289:2122-5. F1000 Factor 10 Evaluated by Roger McIntyre 14 Jun 2012
91. Obici S, Zhang BB, Karkanias G, Rossetti L: Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002, 8:1376-82. F1000 Factor 10 Evaluated by Roger McIntyre 14 Jun 2012
92. Koch L, Wunderlich FT, Seibler J, Könner AC, Hampel B, Irlenbusch S, Brabant G, Kahn CR, Schwenk F, Brüning JC: Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 2008, 118:2132-47. F1000 Factor 9 Evaluated by Joel Elmquist 22 May 2008, Roger McIntyre 14 Jun 2012
93. Könner AC, Hess S, Tovar S, Mesaros A, Sánchez-Lasheras C, Evers N, Verhagen LAW, Brönneke HS, Kleinridders A, Hampel B, Kloppenburg P, Brüning JC: Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab 2011, 13:720-8. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
94. Taguchi A, Wartschow LM, White MF: Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 2007, 317:369-72. F1000 Factor 12 Evaluated by Steven A Rosenzweig 01 Aug 2007, Roger McIntyre 14 Jun 2012
95. Burks DJ, Font Mora J de, Schubert M, Withers DJ, Myers MG, Towery HH, Altamuro SL, Flint CL, White MF: IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000, 407:377-82.
96. Taniguchi CM, Emanuelli B, Kahn CR: Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006, 7:85-96. (Pubitemid 43278292)
97. Wise RA, Rompre PP: Brain dopamine and reward. Annu Rev Psychol 1989, 40:191-225.
98. Volkow ND, Wang G, Baler RD: Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci (Regul Ed) 2011, 15:37-46. F1000 Factor 10 Evaluated by Roger McIntyre 14 Jun 2012
99. Volkow ND, Wise RA: How can drug addiction help us understand obesity? Nat Neurosci 2005, 8:555-60. (Pubitemid 40594193)
100. Kenny PJ: Common cellular and molecular mechanisms in obesity and drug addiction. Nat Rev Neurosci 2011, 12:638-51. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
101. Corsica JA, Pelchat ML: Food addiction: true or false? Curr Opin Gastroenterol 2010, 26:165-9.
102. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS: Brain dopamine and obesity. Lancet 2001, 357:354-7. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
103. Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, Maratos-Flier E, Flier JS: Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-22. F1000 Factor 11 Evaluated by Claire-Dominique Walker 17 Nov 2006, Sadaf Farooqi 06 Feb 2007, Roger McIntyre 14 Jun 2012
104. Roseberry AG, Painter T, Mark GP, Williams JT: Decreased vesicular somatodendritic dopamine stores in leptin-deficient mice. J Neurosci 2007, 27:7021-7. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
105. Bina KG, Cincotta AH: Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology 2000, 71:68-78. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
106. Luo S, Liang Y, Cincotta AH: Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose-intolerant state in hamsters. Neuroendocrinology 1999, 69:160-6. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
107. Figlewicz DP, Szot P, Chavez M, Woods SC, Veith RC: Intraventricular insulin increases dopamine transporter mRNA in rat VTA/substantia nigra. Brain Res 1994, 644:331-4. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
108. Liu Z, Wang Y, Zhao W, Ding J, Mei Z, Guo L, Cui D, Fei J: Peptide derived from insulin with regulatory activity of dopamine transporter. Neuropharmacology 2001, 41:464-71. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
109. Kamei J, Ohsawa M: Effects of diabetes on methamphetamine-induced place preference in mice. Eur J Pharmacol 1996, 318:251-6. (Pubitemid 27046265)
110. Murzi E, Contreras Q, Teneud L, Valecillos B, Parada MA, de Parada MP, Hernandez L: Diabetes decreases limbic extracellular dopamine in rats. Neurosci Lett 1996, 202:141-4. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
111. Iñiguez SD, Warren BL, Neve RL, Nestler EJ, Russo SJ, Bolaños-Guzmán CA: Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine. Behav. Neurosci 2008, 122:1172-7. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
112. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ: IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 2007, 10:93-9. F1000 Factor 6 Evaluated by Mark von Zastrow 09 Jan 2007
113. Zhao W, Chen H, Xu H, Moore E, Meiri N, Quon MJ, Alkon DL: Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem 1999, 274:34893-902. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
114. Reske-Nielsen E, Lundbaek K: Diabetic encephalopathy. Diffuse and focal lesions of the brain in long-term diabetes. Acta Neurol Scand, Suppl 1963, 39(suppl4):273-90.
115. Whitmer RA, Gunderson EP, Barrett-Connor E, Quesenberry CP, Yaffe K: Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ 2005, 330:1360.
116. Whitmer RA, Gustafson DR, Barrett-Connor E, Haan MN, Gunderson EP, Yaffe K: Central obesity and increased risk of dementia more than three decades later. Neurology 2008, 71:1057-64. F1000 Factor 6 Evaluated by Oliver Wolf 08 Oct 2008
117. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D: Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998, 50:164-8. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
118. Craft S, Asthana S, Newcomer JW, Wilkinson CW, Matos IT, Baker LD, Cherrier M, Lofgreen C, Latendresse S, Petrova A, Plymate S, Raskind M, Grimwood K, Veith RC: Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch Gen Psychiatry 1999, 56:1135-40. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
119. Kern W, Peters A, Fruehwald-Schultes B, Deininger E, Born J, Fehm HL: Improving influence of insulin on cognitive functions in humans. Neuroendocrinology 2001, 74:270-80. F1000 Factor 6 Evaluated by Roger McIntyre 14 Jun 2012
120. Fehm HL, Perras B, Smolnik R, Kern W, Born J: Manipulating neuropeptidergic pathways in humans: a novel approach to neuropharmacology? Eur J Pharmacol 2000, 405:43-54.
121. Park CR, Seeley RJ, Craft S, Woods SC: Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav 2000, 68:509-14. (Pubitemid 30129236)
122. Watson GS, Craft S: Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease. Eur J Pharmacol 2004, 490:97-113. (Pubitemid 38482164)
123. de La Monte SM: Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease. Drugs 2012, 72:49-66.
124. Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I: Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002, 8:1390-7. (Pubitemid 36019424)
125. Selkoe DJ: Clearing the brain's amyloid cobwebs. Neuron 2001, 32:177-80.
126. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S: Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U.S.A 2003, 100:4162-7. F1000 Factor 8 Evaluated by Roger McIntyre 14 Jun 2012
127. Ho L, Qin W, Pompl PN, Xiang Z, Wang J, Zhao Z, Peng Y, Cambareri G, Rocher A, Mobbs CV, Hof PR, Pasinetti GM: Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J 2004, 18:902-4.
128. Schubert M, Gautam D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Küstermann E, Arndt S, Jacobs AH, Krone W, Kahn CR, Brüning JC: Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci U.S.A 2004, 101:3100-5. (Pubitemid 38327741)
129. Schubert M, Brazil DP, Burks DJ, Kushner JA, Ye J, Flint CL, Farhang-Fallah J, Dikkes P, Warot XM, Rio C, Corfas G, White MF: Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation. J Neurosci 2003, 23:7084-92. (Pubitemid 36975873)